Search research articles
Contact Us
Filters
Showing results (241-250 of 282) with videos related to
Page
of 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2025
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
Maliazurina B Saad, Eman Showkatian, Vivek Verma, et al.
Frontiers in Oncology
|
November 5, 2021
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
Michael D Chuong, Christopher L Hallemeier, Heng Li, et al.
Cancer Research
|
November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
Xiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with Radiotherapy
Xinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Cancer Research Communications
|
September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC
Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
JAMA Oncology
|
September 19, 2019
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
Dawei Chen, Hari Menon, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 5, 2018
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
Gregory M Videtic, Rebecca Paulus, Anurag K Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2020
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
James W Welsh, John V Heymach, Chunxiao Guo, et al.
The Lancet. Respiratory Medicine
|
October 23, 2020
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen, Dawei Chen, Vivek Verma, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 282) with videos related to
Sort By:
Page
of 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2025
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
Maliazurina B Saad, Eman Showkatian, Vivek Verma, et al.
Frontiers in Oncology
|
November 5, 2021
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
Michael D Chuong, Christopher L Hallemeier, Heng Li, et al.
Cancer Research
|
November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
Xiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with Radiotherapy
Xinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Cancer Research Communications
|
September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC
Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
JAMA Oncology
|
September 19, 2019
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
Dawei Chen, Hari Menon, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 5, 2018
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
Gregory M Videtic, Rebecca Paulus, Anurag K Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 11, 2020
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
James W Welsh, John V Heymach, Chunxiao Guo, et al.
The Lancet. Respiratory Medicine
|
October 23, 2020
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen, Dawei Chen, Vivek Verma, et al.
Page
of 29